Optune Pax is a portable medical device that delivers TTFields non-invasively via wearable arrays to disrupt electrical processes essential for cancer cell division.

Semi-structured interviews with healthcare providers and female cancer survivors explored the perceived benefits of improved nutrition counseling for these survivors.

71 percent of patients had pathological complete response; 7 percent experienced grade 3 treatment-related adverse events.

The phase 2 ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT-PC) trial tested a cooled laser focal therapy device for intermediate-risk prostate cancer treatment.

Researchers evaluated the association between lung cancer risk in never smokers and incidence of TB, asthma, and chronic bronchitis.

Van Der Beek was diagnosed with stage III colorectal cancer after noticing a change in his bowel movements and undergoing a colonoscopy.

Researchers sought to determine an effective approach to predict postembolization fever in patients undergoing TACE.

A structural equation model identified the postoperative effects that are correlated with quality of life for patients with oral cancer.

Researchers conducted a review of studies on AI use in oncology nursing to determine its potential role in clinical practice.

A companion diagnostic test was simultaneously approved to identify eligible patients whose tumors express PD-L1 with a combined positive score of 1 or higher.

Investigators reviewed medical literature to determine the prevalence of breast cancer screening among female survivors of a prior cancer other than breast cancer and to compare the likelihood of ...

The Oncology Nurse Advisor Summit spotlights CAR T-cell therapy, bispecific antibodies, and immunotherapy nursing best practices.